The objective of the Gynecologic Oncology Group (G.O.G.) is the improvement in treatment using a multidisciplinary approach in patients with gynecologic malignancies. The G.O.G. is conducting clinical trials utilizing conventional and investigational modalities including surgery, chemotherapy, radiation therapy, and immunotherapy applied to cancers of the vulva, vagina, cervix, uterus, and ovary as well as Gestational trophoblastic disease. Tufts-New England Medical Center is a full member of the Gynecologic Oncology Group and Massachusetts General Hospital is an affiliate member. Tufts-New England Medical Center supports and participates in all activities of the G.O.G. including entering patients onto appropriate studies, providing follow-up data on all patients attending G.O.G. business meetings, and providing expertise to aid in developing new protocols.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA037569-04
Application #
3558182
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1984-07-01
Project End
1989-06-30
Budget Start
1987-05-01
Budget End
1989-06-30
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02111